Skip to main content
. 2022 Nov 1;379:e071380. doi: 10.1136/bmj-2022-071380

Fig 4.

Fig 4

Weighted cumulative incidence curves of severe chronic obstructive pulmonary disease (COPD) exacerbations in dipeptidyl peptidase-4 (DPP-4) inhibitor versus sulfonylurea cohort